Skip to main content
NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.87
-0.16 (-1.14%)
Mar 9, 2026, 2:34 PM EDT - Market open

NeuroPace Revenue

In the year 2025, NeuroPace had annual revenue of $99.99M with 25.13% growth. NeuroPace had revenue of $26.59M in the quarter ending December 31, 2025, with 23.86% growth.

Revenue (ttm)
$99.99M
Revenue Growth
+25.13%
P/S Ratio
4.64
Revenue / Employee
$478,402
Employees
209
Market Cap
466.96M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202599.99M20.08M25.13%
Dec 31, 202479.91M14.48M22.14%
Dec 31, 202365.42M19.90M43.72%
Dec 31, 202245.52M337.00K0.75%
Dec 31, 202145.18M4.05M9.83%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 854.40M
Orthofix Medical 822.31M
Bioventus 568.09M
OrthoPediatrics 236.35M
Cerus 206.13M
Cytek Biosciences 201.49M
Pacific Biosciences of California 160.01M
Beta Bionics 100.25M
Revenue Rankings

NPCE News

More News